Concepedia

Tyler Brady

TB

Statistics

Publications

12

Citations

723

H-Index

12

Active since

2017

Affiliations

AstraZeneca (United States)(Current)

National Institute of Allergy and Infectious Diseases

National Institutes of Health

University of Maryland, College Park

Howard Hughes Medical Institute

Tyler Brady is an author at AstraZeneca (United States) specializing in infectious diseases, viral infections, and life sciences.

ORCID

Publications per year

2017–2024

12

Publications

12

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail

Jinhui Dong, Seth J. Zost, Allison J. Greaney et al. · Nature Microbiology · 2021 · 330 citations · Full text

, , +17

Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data

Deidre Wilkins, Annefleur C Langedijk, Robert Jan Lebbink et al. · The Lancet Infectious Diseases · 2023 · 105 citations

, , +14

Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail

Jinhui Dong, Seth J. Zost, Allison J. Greaney et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 67 citations · Full text

, , +17

A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene

Yíngyún Caì, Chengjin Ye, Benson Yee Hin Cheng et al. · mBio · 2020 · 48 citations · Full text

, , +17

Transfer of bacteriophage MS2 and fluorescein from N95 filtering facepiece respirators to hands: Measuring fomite potential

Tyler Brady, Amanda Strauch, Claudia M. Almaguer et al. · Journal of Occupational and Environmental Hygiene · 2017 · 36 citations · Full text

, , +14

1–5 of 12